{Reference Type}: Case Reports
{Title}: Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases.
{Author}: Hodson EL;Kranyak A;Salem I;Buckey JC;
{Journal}: J Tissue Viability
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 5
{Factor}: 3.374
{DOI}: 10.1016/j.jtv.2024.06.001
{Abstract}: BACKGROUND: Pyoderma gangrenosum (PG) is a rare, difficult-to-treat neutrophilic ulcerative cutaneous condition that severely impacts those affected. Treatment options for PG are limited, and disease remission is not guaranteed. Hyperbaric oxygen treatment is a potential therapeutic option for treating various ulcerative conditions not frequently utilized for PG.
METHODS: We present a case of a patient with treatment-resistant PG who achieved remission with adjunctive HBOT, and then later had difficulty achieving remission without HBOT during a future flare.
CONCLUSIONS: HBOT should be more readily considered as a treatment option for those with PG.